Tag
Satish Kumar Sharma
2 articles
Mankind Pharma Q4 Net Profit Rises to ₹713.61 Crore
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting ₹713.61 crore quarterly net profit.
Approved ₹500 crore additional investment in whol
Mankind Pharma FY26 Results, Board Decisions, Subsidiary Investment
Board approved audited standalone and consolidated FY26 results with revenue of ₹10,421.18 crore and net profit of ₹2,037.56 crore.
Approved additional investment of up to ₹500 crore in wholly-owned s